Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH6 DNAH9 DYNC1H1 DNAH11	4.46e-06	18	127	4	GO:0008569
GeneOntologyMolecularFunction	pyrophosphatase activity	ENPP3 PSMC2 PEX1 ATP8B1 RGS1 RGS7 RGS14 ABCG1 RGS8 GNA15 DDX39A DNAH6 DNAH9 ATP2B2 DDX39B DYNC1H1 DNAH11	2.35e-05	839	127	17	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ENPP3 PSMC2 PEX1 ATP8B1 RGS1 RGS7 RGS14 ABCG1 RGS8 GNA15 DDX39A DNAH6 DNAH9 ATP2B2 DDX39B DYNC1H1 DNAH11	2.39e-05	840	127	17	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ENPP3 PSMC2 PEX1 ATP8B1 RGS1 RGS7 RGS14 ABCG1 RGS8 GNA15 DDX39A DNAH6 DNAH9 ATP2B2 DDX39B DYNC1H1 DNAH11	2.39e-05	840	127	17	GO:0016818
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH6 DNAH9 DYNC1H1 DNAH11	2.84e-05	28	127	4	GO:0051959
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	PSMC2 PEX1 ATP8B1 RGS1 RGS7 RGS14 ABCG1 RGS8 GNA15 DDX39A DNAH6 DNAH9 ATP2B2 DDX39B DYNC1H1 DNAH11	3.33e-05	775	127	16	GO:0017111
GeneOntologyMolecularFunction	glucosamine-6-phosphate deaminase activity	GNPDA1 GNPDA2	4.01e-05	2	127	2	GO:0004342
GeneOntologyMolecularFunction	bone sialoprotein binding	ANXA2 ANXA2P2	4.01e-05	2	127	2	GO:0044730
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH6 DNAH9 DYNC1H1 DNAH11	8.76e-05	37	127	4	GO:0045505
GeneOntologyMolecularFunction	ATP hydrolysis activity	PSMC2 PEX1 ATP8B1 ABCG1 DDX39A DNAH6 DNAH9 ATP2B2 DDX39B DYNC1H1 DNAH11	1.20e-04	441	127	11	GO:0016887
GeneOntologyMolecularFunction	G-protein alpha-subunit binding	RGS1 RGS7 RGS14 RGS8	1.59e-04	43	127	4	GO:0001965
GeneOntologyMolecularFunction	phospholipase A2 inhibitor activity	ANXA2 ANXA2P2	3.96e-04	5	127	2	GO:0019834
GeneOntologyMolecularFunction	ATP-dependent activity	IPO8 PSMC2 PEX1 ATP8B1 ABCG1 DDX39A DNAH6 DNAH9 ATP2B2 DDX39B DYNC1H1 DNAH11	5.53e-04	614	127	12	GO:0140657
GeneOntologyMolecularFunction	histone H3K9me2/H3K9me3 demethylase activity	KDM4C KDM4B	5.92e-04	6	127	2	GO:0140684
GeneOntologyMolecularFunction	calcium ion binding	ANXA2 ANXA2P2 ENPP3 ACTN4 SELENON MELK LRP8 SCUBE1 SULF2 SCUBE2 LOXL2 MMP12 ATP2B2	9.79e-04	749	127	13	GO:0005509
GeneOntologyMolecularFunction	microtubule motor activity	DNAH6 DNAH9 DYNC1H1 DNAH11	1.03e-03	70	127	4	GO:0003777
GeneOntologyMolecularFunction	phosphatidylcholine floppase activity	ATP8B1 ABCG1	1.10e-03	8	127	2	GO:0090554
GeneOntologyBiologicalProcess	positive regulation of intracellular transport	MAP2 ANXA2 ANXA2P2 PTGS2 MAVS PRKCQ RIOK2 DYNC1H1	6.98e-06	162	126	8	GO:0032388
GeneOntologyBiologicalProcess	positive regulation of low-density lipoprotein particle receptor binding	ANXA2 ANXA2P2	3.70e-05	2	126	2	GO:1905597
GeneOntologyBiologicalProcess	glucosamine catabolic process	GNPDA1 GNPDA2	3.70e-05	2	126	2	GO:0006043
GeneOntologyBiologicalProcess	collagen fibril organization	ANXA2 ANXA2P2 SELENON VPS33B LOXL2	1.03e-04	76	126	5	GO:0030199
GeneOntologyBiologicalProcess	positive regulation of receptor-mediated endocytosis involved in cholesterol transport	ANXA2 ANXA2P2	1.11e-04	3	126	2	GO:1905602
GeneOntologyBiologicalProcess	negative regulation of low-density lipoprotein particle receptor catabolic process	ANXA2 ANXA2P2	1.11e-04	3	126	2	GO:0032804
GeneOntologyBiologicalProcess	N-acetylglucosamine catabolic process	GNPDA1 GNPDA2	1.11e-04	3	126	2	GO:0006046
GeneOntologyBiologicalProcess	positive regulation of low-density lipoprotein particle clearance	ANXA2 ANXA2P2	2.20e-04	4	126	2	GO:1905581
GeneOntologyBiologicalProcess	negative regulation of receptor catabolic process	ANXA2 ANXA2P2	2.20e-04	4	126	2	GO:2000645
GeneOntologyBiologicalProcess	positive regulation of intracellular cholesterol transport	ANXA2 ANXA2P2	2.20e-04	4	126	2	GO:0032385
GeneOntologyBiologicalProcess	positive regulation of intracellular sterol transport	ANXA2 ANXA2P2	2.20e-04	4	126	2	GO:0032382
GeneOntologyBiologicalProcess	regulation of plasma membrane organization	ANXA2 ANXA2P2 ATP8B1	2.35e-04	20	126	3	GO:1903729
GeneOntologyBiologicalProcess	copper ion transport	STEAP4 CP SLC46A3	2.35e-04	20	126	3	GO:0006825
GeneOntologyCellularComponent	microtubule associated complex	MAP2 LRP8 PXN DNAH6 DNAH9 DYNC1H1 DNAH11	6.11e-05	161	128	7	GO:0005875
GeneOntologyCellularComponent	fatty acid beta-oxidation multienzyme complex	ACACB HADHB	1.11e-04	3	128	2	GO:0036125
GeneOntologyCellularComponent	mitochondrial fatty acid beta-oxidation multienzyme complex	ACACB HADHB	1.11e-04	3	128	2	GO:0016507
GeneOntologyCellularComponent	AnxA2-p11 complex	ANXA2 ANXA2P2	1.11e-04	3	128	2	GO:1990665
GeneOntologyCellularComponent	PCSK9-AnxA2 complex	ANXA2 ANXA2P2	1.11e-04	3	128	2	GO:1990667
GeneOntologyCellularComponent	dynein complex	DNAH6 DNAH9 DYNC1H1 DNAH11	3.35e-04	54	128	4	GO:0030286
GeneOntologyCellularComponent	CCR4-NOT core complex	CNOT8 CNOT7	5.49e-04	6	128	2	GO:0030015
GeneOntologyCellularComponent	myelin sheath adaxonal region	ANXA2 ANXA2P2	7.66e-04	7	128	2	GO:0035749
GeneOntologyCellularComponent	pericentric heterochromatin	KDM4C BAZ1B KDM4B	9.77e-04	32	128	3	GO:0005721
GeneOntologyCellularComponent	cell leading edge	FGD2 MAP2 ANXA2 ANXA2P2 PECAM1 GABARAPL1 PTPRO SYNE2 PXN ATP2B2	1.03e-03	500	128	10	GO:0031252
Domain	Dynein_heavy_chain_D4_dom	DNAH6 DNAH9 DYNC1H1 DNAH11	1.76e-06	14	124	4	IPR024317
Domain	Dynein_HC_stalk	DNAH6 DNAH9 DYNC1H1 DNAH11	1.76e-06	14	124	4	IPR024743
Domain	Dynein_heavy_dom-2	DNAH6 DNAH9 DYNC1H1 DNAH11	1.76e-06	14	124	4	IPR013602
Domain	DHC_N2	DNAH6 DNAH9 DYNC1H1 DNAH11	1.76e-06	14	124	4	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH6 DNAH9 DYNC1H1 DNAH11	1.76e-06	14	124	4	IPR011704
Domain	MT	DNAH6 DNAH9 DYNC1H1 DNAH11	1.76e-06	14	124	4	PF12777
Domain	AAA_8	DNAH6 DNAH9 DYNC1H1 DNAH11	1.76e-06	14	124	4	PF12780
Domain	AAA_5	DNAH6 DNAH9 DYNC1H1 DNAH11	1.76e-06	14	124	4	PF07728
Domain	DHC_fam	DNAH6 DNAH9 DYNC1H1 DNAH11	2.39e-06	15	124	4	IPR026983
Domain	Dynein_heavy	DNAH6 DNAH9 DYNC1H1 DNAH11	2.39e-06	15	124	4	PF03028
Domain	Dynein_heavy_dom	DNAH6 DNAH9 DYNC1H1 DNAH11	2.39e-06	15	124	4	IPR004273
Domain	-	RGS1 RGS7 RGS14 RGS8	1.23e-05	22	124	4	1.10.196.10
Domain	RGS_subdom1	RGS1 RGS7 RGS14 RGS8	1.23e-05	22	124	4	IPR024066
Domain	DHC_N1	DNAH9 DYNC1H1 DNAH11	1.56e-05	8	124	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH9 DYNC1H1 DNAH11	1.56e-05	8	124	3	IPR013594
Domain	Glucosamine6P_isomerase_CS	GNPDA1 GNPDA2	4.37e-05	2	124	2	IPR018321
Domain	Glucosamine6P_isomerase	GNPDA1 GNPDA2	4.37e-05	2	124	2	IPR004547
Domain	GLC_GALNAC_ISOMERASE	GNPDA1 GNPDA2	4.37e-05	2	124	2	PS01161
Domain	AAA	PSMC2 PEX1 ABCG1 DNAH6 DNAH9 DYNC1H1 DNAH11	4.97e-05	144	124	7	SM00382
Domain	AAA+_ATPase	PSMC2 PEX1 ABCG1 DNAH6 DNAH9 DYNC1H1 DNAH11	4.97e-05	144	124	7	IPR003593
Domain	RGS	RGS1 RGS7 RGS14 RGS8	8.26e-05	35	124	4	PF00615
Domain	RGS	RGS1 RGS7 RGS14 RGS8	8.26e-05	35	124	4	SM00315
Domain	RGS	RGS1 RGS7 RGS14 RGS8	9.25e-05	36	124	4	PS50132
Domain	RGS	RGS1 RGS7 RGS14 RGS8	1.27e-04	39	124	4	IPR016137
Domain	Glc/Gal-6P_isomerase	GNPDA1 GNPDA2	2.60e-04	4	124	2	IPR006148
Domain	Glucosamine_iso	GNPDA1 GNPDA2	2.60e-04	4	124	2	PF01182
Domain	RNase_CAF1	CNOT8 CNOT7	4.32e-04	5	124	2	IPR006941
Domain	CAF1	CNOT8 CNOT7	4.32e-04	5	124	2	PF04857
Domain	Atg8	GABARAPL1 GABARAPL3	1.19e-03	8	124	2	PF02991
Domain	Atg8-like	GABARAPL1 GABARAPL3	1.19e-03	8	124	2	IPR004241
Domain	-	GNL3L PSMC2 PEX1 URGCP ABCG1 GNA15 DSEL DDX39A DNAH6 DNAH9 DDX39B DYNC1H1 DNAH11	1.38e-03	746	124	13	3.40.50.300
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	GNL3L TUT7 PSMC2 BAZ1B ACTN4 NOL10 MELK TGM1 GTF2H1 FAM120A VPS33B MICAL2 UBTF TIMM50 ATIC HADHB DDX39A RIOK2 ZNF281 DDX39B DYNC1H1	2.44e-08	1353	128	21	29467282
Pubmed	Prostaglandin-endoperoxide synthase-2 deletion affects the natural trafficking of Annexin A2 in monocytes and favours venous thrombosis in mice.	ANXA2 ANXA2P2 PTGS2	4.87e-08	3	128	3	28536720
Pubmed	Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma.	RGS1 RGS7 RGS14 RGS8	4.01e-07	17	128	4	20627871
Pubmed	Splicing variations in the ligand-binding domain of ApoER2 results in functional differences in the binding properties to Reelin.	RELN MAP2 LRP8	4.84e-07	5	128	3	19167437
Pubmed	A novel regulator of G-protein signaling bearing GAP activity for Galphai and Galphaq in megakaryocytes.	RGS1 RGS7 RGS14 RGS8	6.50e-07	19	128	4	11342430
Pubmed	Multiple mouse chromosomal loci for dynein-based motility.	NEB MMP12 DNAH6 DNAH9 DYNC1H1	8.46e-07	47	128	5	8812413
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	ELOA UGGT1 PSMC2 PPP4R3A VPS33B INTS13 CNOT7 TIMM50 CSTF3 TMPO HADHB DYNC1H1	1.18e-06	560	128	12	35241646
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ELOA UGGT1 CCDC18 PSMC2 ACTN4 NOL10 PPP4R3A VPS33B UBTF SVIL SYNE2 TIMM50 PXN CSTF3 TMPO HADHB	1.66e-06	1049	128	16	27880917
Pubmed	Downregulation of functional Reelin receptors in projection neurons implies that primary Reelin action occurs at early/premigratory stages.	RELN MAP2 LRP8	1.69e-06	7	128	3	19710317
Pubmed	Regulation of error-prone translesion synthesis by Spartan/C1orf124.	ANXA2 PSMC2 FAM120A TMPO DYNC1H1	2.66e-06	59	128	5	23254330
Pubmed	Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2.	RELN MAP2 LRP8	2.69e-06	8	128	3	10380922
Pubmed	Rescue of ataxia and preplate splitting by ectopic expression of Reelin in reeler mice.	RELN MAP2 LRP8	2.69e-06	8	128	3	11856531
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	IPO8 ACACB ANXA2 TUT7 PSMC2 CP ACTN4 FAM120A MAVS VPS33B SVIL TIMM50 PXN DYNC1H1	3.37e-06	853	128	14	28718761
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ELOA GNL3L ANXA2 UGGT1 TUT7 BAZ1B ACTN4 NOL10 GTF2H1 FAM120A UBTF SVIL TIMM50 TMPO HADHB DDX39B DYNC1H1	3.86e-06	1257	128	17	36526897
Pubmed	Reelin stabilizes the actin cytoskeleton of neuronal processes by inducing n-cofilin phosphorylation at serine3.	RELN MAP2 LRP8	4.02e-06	9	128	3	19129405
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	IPO8 NELFCD USP24 PSMC2 ACTN4 PPP4R3A TIMM50 CSTF3 TMPO HADHB DDX39B DYNC1H1	4.49e-06	638	128	12	33239621
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	GNL3L IPO8 ANXA2 UGGT1 BAZ1B NIPSNAP3A ACTN4 NOL10 FAM120A VPS33B UBTF TIMM50 CSTF3 TMPO ATIC HADHB DDX39B DYNC1H1	5.03e-06	1425	128	18	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MAP2 ANXA2 ANXA2P2 ACTN4 PTGS2 TGM1 FAM120A SV2B SRGAP3 MICAL2 SVIL TMPO HADHB DNAH6 ATP2B2 DDX39B DYNC1H1 DNAH11	5.33e-06	1431	128	18	37142655
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	UGGT1 TUT7 USP24 PSMC2 BAZ1B ACTN4 NOL10 FAM120A UBTF SYNE2 ATIC DYNC1H1	5.68e-06	653	128	12	22586326
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	IPO8 ACACB ANXA2 ACTN4 TRIM24 TGM1 ZNF281 DDX39B DYNC1H1	7.46e-06	357	128	9	37059091
Pubmed	ApoER2 Controls Not Only Neuronal Migration in the Intermediate Zone But Also Termination of Migration in the Developing Cerebral Cortex.	RELN MAP2 LRP8	7.86e-06	11	128	3	27909010
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	IPO8 ACACB PSMC2 ACTN4 PPP4R3A PTPRO INTS13 TIMM50 HADHB DDX39A DYNC1H1	9.45e-06	573	128	11	28330616
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	GNL3L ANXA2 ANXA2P2 ACTN4 NOL10 TGM1 FAM120A GABARAPL1 UBTF SVIL DDX39A RIOK2 DDX39B DYNC1H1	1.13e-05	949	128	14	36574265
Pubmed	Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease.	RELN LRP8	1.34e-05	2	128	2	29442527
Pubmed	Nuclear localization of poly(A)+ mRNA following siRNA reduction of expression of the mammalian RNA helicases UAP56 and URH49.	DDX39A DDX39B	1.34e-05	2	128	2	16949217
Pubmed	Conservation of the deadenylase activity of proteins of the Caf1 family in human.	CNOT8 CNOT7	1.34e-05	2	128	2	15769875
Pubmed	Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study.	GNPDA1 GNPDA2	1.34e-05	2	128	2	12965206
Pubmed	Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.	ANXA2 ANXA2P2	1.34e-05	2	128	2	19536308
Pubmed	Cloning and functional characterization of GNPI2, a novel human homolog of glucosamine-6-phosphate isomerase/oscillin.	GNPDA1 GNPDA2	1.34e-05	2	128	2	12616532
Pubmed	Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate.	ANXA2 ANXA2P2	1.34e-05	2	128	2	23148505
Pubmed	Binding of the human cytomegalovirus (HCMV) tegument protein UL69 to UAP56/URH49 is not required for efficient replication of HCMV.	DDX39A DDX39B	1.34e-05	2	128	2	20610707
Pubmed	ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.	ANXA2 ANXA2P2	1.34e-05	2	128	2	38290972
Pubmed	The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats.	ANXA2 ANXA2P2	1.34e-05	2	128	2	3013423
Pubmed	Activation of Annexin A2 signaling at the blood-brain barrier in a mouse model of multiple sclerosis.	ANXA2 ANXA2P2	1.34e-05	2	128	2	35064931
Pubmed	Structural differences between the closely related RNA helicases, UAP56 and URH49, fashion distinct functional apo-complexes.	DDX39A DDX39B	1.34e-05	2	128	2	38225262
Pubmed	Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans.	ANXA2 ANXA2P2	1.34e-05	2	128	2	28130864
Pubmed	Localization of annexin II in the paranodal regions and Schmidt-Lanterman incisures in the peripheral nervous system.	ANXA2 ANXA2P2	1.34e-05	2	128	2	17549680
Pubmed	Annexin A2 promotes proliferative vitreoretinopathy in response to a macrophage inflammatory signal in mice.	ANXA2 ANXA2P2	1.34e-05	2	128	2	39384746
Pubmed	Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells.	ANXA2 ANXA2P2	1.34e-05	2	128	2	20826156
Pubmed	Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue.	ANXA2 ANXA2P2	1.34e-05	2	128	2	27468426
Pubmed	Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.	ANXA2 ANXA2P2	1.34e-05	2	128	2	19841537
Pubmed	Annexin A2 Modulates ROS and Impacts Inflammatory Response via IL-17 Signaling in Polymicrobial Sepsis Mice.	ANXA2 ANXA2P2	1.34e-05	2	128	2	27389701
Pubmed	LRP8-Reelin-Regulated Neuronal Enhancer Signature Underlying Learning and Memory Formation.	RELN LRP8	1.34e-05	2	128	2	25892301
Pubmed	Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation.	ANXA2 ANXA2P2	1.34e-05	2	128	2	17360942
Pubmed	Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina.	ANXA2 ANXA2P2	1.34e-05	2	128	2	19587120
Pubmed	Annexin A2 at the interface between F-actin and membranes enriched in phosphatidylinositol 4,5,-bisphosphate.	ANXA2 ANXA2P2	1.34e-05	2	128	2	19022301
Pubmed	A secreted soluble form of ApoE receptor 2 acts as a dominant-negative receptor and inhibits Reelin signaling.	RELN LRP8	1.34e-05	2	128	2	12426372
Pubmed	Multi-Omics Profiling Identifies Microglial Annexin A2 as a Key Mediator of NF-κB Pro-inflammatory Signaling in Ischemic Reperfusion Injury.	ANXA2 ANXA2P2	1.34e-05	2	128	2	38253182
Pubmed	Each actin subunit has three nebulin binding sites: implications for steric blocking.	ACTN4 NEB	1.34e-05	2	128	2	11882289
Pubmed	Parsing the roles of DExD-box proteins DDX39A and DDX39B in alternative RNA splicing.	DDX39A DDX39B	1.34e-05	2	128	2	38801080
Pubmed	Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis.	ANXA2 ANXA2P2	1.34e-05	2	128	2	22185818
Pubmed	Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density.	RELN LRP8	1.34e-05	2	128	2	21852430
Pubmed	Distinct and combinatorial functions of Jmjd2b/Kdm4b and Jmjd2c/Kdm4c in mouse embryonic stem cell identity.	KDM4C KDM4B	1.34e-05	2	128	2	24361252
Pubmed	A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events.	ANXA2 ANXA2P2	1.34e-05	2	128	2	21486955
Pubmed	Terminal regions of UAP56 and URH49 are required for their distinct complex formation functioning to an essential role in mRNA processing and export.	DDX39A DDX39B	1.34e-05	2	128	2	38377942
Pubmed	Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2.	ANXA2 ANXA2P2	1.34e-05	2	128	2	21737841
Pubmed	Structural basis for ligand capture and release by the endocytic receptor ApoER2.	RELN LRP8	1.34e-05	2	128	2	28446613
Pubmed	Regulation of the low-dose radiation paracrine-specific anchorage-independent growth response by annexin A2.	ANXA2 ANXA2P2	1.34e-05	2	128	2	19580511
Pubmed	Dentate granule cells in reeler mutants and VLDLR and ApoER2 knockout mice.	RELN LRP8	1.34e-05	2	128	2	12093079
Pubmed	Selenomethionine promotes ANXA2 phosphorylation for proliferation and protein synthesis of myoblasts and skeletal muscle growth.	ANXA2 ANXA2P2	1.34e-05	2	128	2	36739096
Pubmed	Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia.	ANXA2 ANXA2P2	1.34e-05	2	128	2	22517898
Pubmed	Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-κB signaling pathway.	ANXA2 ANXA2P2	1.34e-05	2	128	2	30462534
Pubmed	Archvillin anchors in the Z-line of skeletal muscle via the nebulin C-terminus.	NEB SVIL	1.34e-05	2	128	2	18639526
Pubmed	CNOT7 Outcompetes Its Paralog CNOT8 for Integration into The CCR4-NOT Complex.	CNOT8 CNOT7	1.34e-05	2	128	2	35248544
Pubmed	Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis.	ANXA2 ANXA2P2	1.34e-05	2	128	2	38092984
Pubmed	Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.	ANXA2 ANXA2P2	1.34e-05	2	128	2	21572519
Pubmed	Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice.	ANXA2 ANXA2P2	1.34e-05	2	128	2	21788340
Pubmed	The Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferation.	CNOT8 CNOT7	1.34e-05	2	128	2	19605561
Pubmed	The Membrane Phospholipid Binding Protein Annexin A2 Promotes Phagocytosis and Nonlytic Exocytosis of Cryptococcus neoformans and Impacts Survival in Fungal Infection.	ANXA2 ANXA2P2	1.34e-05	2	128	2	27371724
Pubmed	Congruence of vascular network remodeling and neuronal dispersion in the hippocampus of reelin-deficient mice.	RELN PECAM1	1.34e-05	2	128	2	22261923
Pubmed	Annexin A2 Deficiency Exacerbates Neuroinflammation and Long-Term Neurological Deficits after Traumatic Brain Injury in Mice.	ANXA2 ANXA2P2	1.34e-05	2	128	2	31817350
Pubmed	ANNEXIN A2 FACILITATES NEOVASCULARIZATION TO PROTECT AGAINST MYOCARDIAL INFARCTION INJURY VIA INTERACTING WITH MACROPHAGE YAP AND ENDOTHELIAL INTEGRIN Β3.	ANXA2 ANXA2P2	1.34e-05	2	128	2	37832154
Pubmed	Cell-surface translocation of annexin A2 contributes to bleomycin-induced pulmonary fibrosis by mediating inflammatory response in mice.	ANXA2 ANXA2P2	1.34e-05	2	128	2	30902828
Pubmed	The closely related RNA helicases, UAP56 and URH49, preferentially form distinct mRNA export machineries and coordinately regulate mitotic progression.	DDX39A DDX39B	1.34e-05	2	128	2	20573985
Pubmed	Cell surface translocation of annexin A2 facilitates glutamate-induced extracellular proteolysis.	ANXA2 ANXA2P2	1.34e-05	2	128	2	24742684
Pubmed	Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections.	ANXA2 ANXA2P2	1.34e-05	2	128	2	32687500
Pubmed	Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris.	ANXA2 ANXA2P2	1.34e-05	2	128	2	22453828
Pubmed	Agents that bind annexin A2 suppress ocular neovascularization.	ANXA2 ANXA2P2	1.34e-05	2	128	2	20607799
Pubmed	A new role for host annexin A2 in establishing bacterial adhesion to vascular endothelial cells: lines of evidence from atomic force microscopy and an in vivo study.	ANXA2 ANXA2P2	1.34e-05	2	128	2	31253864
Pubmed	Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo.	ANXA2 ANXA2P2	1.34e-05	2	128	2	19628708
Pubmed	Annexin A2 binds to the localization signal in the 3' untranslated region of c-myc mRNA.	ANXA2 ANXA2P2	1.34e-05	2	128	2	15654879
Pubmed	Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis.	ANXA2 ANXA2P2	1.34e-05	2	128	2	20847146
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	GNPDA1 MAP2 ANXA2 USP24 PPP4R3A SRGAP3 SVIL SYNE2 PXN TMPO	1.66e-05	498	128	10	36634849
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH6 DYNC1H1 DNAH11	1.72e-05	14	128	3	9373155
Pubmed	USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c.	ELOA ACACB BAZ1B ZNF281 DYNC1H1	2.14e-05	90	128	5	35654790
Pubmed	Genetic dissection of plexin signaling in vivo.	RELN MAP2 PECAM1	2.14e-05	15	128	3	24469813
Pubmed	Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum.	IYD SV2B ATP2B2	2.14e-05	15	128	3	19043545
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	ANXA2 PSMC2 ACTN4 TGM1 SVIL TIMM50 HADHB DYNC1H1	2.16e-05	312	128	8	37120454
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ANXA2 UGGT1 BAZ1B ACTN4 UBTF SVIL SYNE2 TIMM50 CSTF3 TMPO ATIC HADHB DDX39B DYNC1H1	2.61e-05	1024	128	14	24711643
Pubmed	Embryonic and postnatal development of mouse olfactory tubercle.	RELN MAP2 PECAM1	2.63e-05	16	128	3	31200100
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	NELFCD BAZ1B NOL10 GTF2H1 INTS13 UBTF TIMM50 TMPO ZNF281 DYNC1H1	2.96e-05	533	128	10	30554943
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	BAZ1B ACTN4 LOXL2 SVIL SLC4A5 DDX39B DYNC1H1 SEC14L5	3.36e-05	332	128	8	37433992
Pubmed	Evolution of the regulators of G-protein signaling multigene family in mouse and human.	RGS1 RGS7 RGS14 RGS8	3.83e-05	51	128	4	11829488
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	BAZ1B NOL10 UBTF CSTF3 TMPO HADHB DDX39A DYNC1H1	3.97e-05	340	128	8	29478914
Pubmed	STARD3NL inhibits the osteogenic differentiation by inactivating the Wnt/β-catenin pathway via binding to Annexin A2 in osteoporosis.	ANXA2 ANXA2P2	4.02e-05	3	128	2	35098646
Pubmed	Disruption of the dynein-dynactin complex unveils motor-specific functions in osteoclast formation and bone resorption.	DYNC1H1 DNAH11	4.02e-05	3	128	2	22887640
Pubmed	Reelin together with ApoER2 regulates interneuron migration in the olfactory bulb.	RELN LRP8	4.02e-05	3	128	2	23209795
Pubmed	The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression.	ANXA2 ANXA2P2	4.02e-05	3	128	2	35413401
Pubmed	Reelin, very-low-density lipoprotein receptor, and apolipoprotein E receptor 2 control somatic NMDA receptor composition during hippocampal maturation in vitro.	RELN LRP8	4.02e-05	3	128	2	15987942
Pubmed	Annexin A2 supports pulmonary microvascular integrity by linking vascular endothelial cadherin and protein tyrosine phosphatases.	ANXA2 ANXA2P2	4.02e-05	3	128	2	28694388
GeneFamily	Regulators of G-protein signaling	RGS1 RGS7 RGS14 RGS8	2.11e-06	21	81	4	720
GeneFamily	Dyneins, axonemal	DNAH6 DNAH9 DNAH11	5.63e-05	17	81	3	536
GeneFamily	CCR4-NOT transcription complex	CNOT8 CNOT7	1.06e-03	11	81	2	1023
Coexpression	GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP	NPTX1 BAZ1B NEB CHN1 LOXL2 TOMM34 ATP2B2 ANO3	5.42e-06	195	128	8	M8421
Coexpression	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	NPTX1 RBL2 STEAP4 CP ATP8B1 PTGS2 CNOT8 SLC46A3 MAVS LOXL2 SYNE2 GNA15 KDM4B	1.79e-05	648	128	13	M14371
Coexpression	CHICAS_RB1_TARGETS_CONFLUENT	RELN NPTX1 ANXA2 ANXA2P2 NIPSNAP3A ACTN4 ATP8B1 CHN1 MELK LOXL2 PXN SPOCD1	2.28e-05	567	128	12	M2129
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1	RGS1 PTGS2 SLC46A3 SULF2 MMP12	7.80e-05	75	124	5	GSM605826_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#1	MAP2 MANEA SCUBE1 RGS8 HOXC8 SRGAP3 ATP2B2	8.24e-05	177	124	7	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K1
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2	RGS1 PTGS2 SLC46A3 SULF2 MMP12	9.40e-05	78	124	5	GSM538266_100
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1	RGS1 PTGS2 SLC46A3 SULF2 MMP12	9.99e-05	79	124	5	GSM538265_100
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#3_top-relative-expression-ranked_100	ENPP3 PECAM1	1.01e-04	3	124	2	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k3_100
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_100	ENPP3 PECAM1	1.01e-04	3	124	2	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k3_100
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#1_top-relative-expression-ranked_100	ENPP3 PECAM1	1.01e-04	3	124	2	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k1_100
CoexpressionAtlas	dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#2_top-relative-expression-ranked_100	ENPP3 PECAM1	1.01e-04	3	124	2	gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k2_100
CoexpressionAtlas	dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_200	ENPP3 PECAM1	1.01e-04	3	124	2	gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_200
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_200	ENPP3 PECAM1	1.01e-04	3	124	2	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k1_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	OMA1 MAP2 MANEA ABCG1 SCUBE1 RGS8 HOXC8 SRGAP3 CNOT7 ATP2B2	1.78e-04	419	124	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K1
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_100	ENPP3 PECAM1	2.01e-04	4	124	2	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_100
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PECAM1 CP ATP8B1 CHN1 ABCG1 SULF2 SYNE2 ARHGEF3 MPPED2	4.79e-09	192	128	9	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPTX1 CHN1 SV2B MICAL2 ARHGEF3 DNAH6 ANO3 SEC14L5	6.87e-08	186	128	8	84ba666237c18189d7e7556bd92dd953af733c00
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPTX1 CHN1 SV2B MICAL2 DNAH6 MPPED2 ANO3 SEC14L5	7.46e-08	188	128	8	50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPTX1 DPP10 CHN1 SV2B MICAL2 DNAH6 ANO3 SEC14L5	7.77e-08	189	128	8	a75226616340045b581d08429d2e123e041dee55
ToppCell	Neuronal-Excitatory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NPTX1 DPP10 CHN1 SV2B MICAL2 DNAH6 ANO3 SEC14L5	1.20e-07	200	128	8	4409065bc7aa995354c71e0f9d6f3726cf393d6b
ToppCell	Children_(3_yrs)-Immune-dendritic_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FGD2 RGS1 RGS7 LRP8 SULF2 LOXL2 CCR6	6.50e-07	171	128	7	6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PECAM1 CHN1 ABCG1 SCUBE1 SULF2 SV2B PXN	1.27e-06	189	128	7	c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPTX1 CHN1 SV2B MICAL2 DNAH6 ANO3 SEC14L5	1.32e-06	190	128	7	49e09cdb843b3d889a06a811aa5affae68b25a75
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPTX1 DPP10 CHN1 SV2B MICAL2 ARHGEF3 ANO3	1.41e-06	192	128	7	5c7e8b80b44d9ce55c797cdf8267ac5382e26cac
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KDM4C ENPP3 USP24 LRP8 SYNE2 PRKCQ DDX39B	1.68e-06	197	128	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-mDC\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	GPD1 FGD2 TMPRSS12 RGS1 SULF2 PTPRO GNA15	1.73e-06	198	128	7	d11097254791e415bf60a847feac81f400f11664
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	GPD1 FGD2 TMPRSS12 RGS1 SULF2 PTPRO GNA15	1.73e-06	198	128	7	b2c8d5956f8449df4b69fb1b30632253440f815e
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RGS1 SULF2 LOXL2 TOMM34 GNA15 CCR6 MMP12	1.79e-06	199	128	7	6fc8c321e2ddd802b9c8edfe16e006c7d4d862fc
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FGD2 RGS1 SULF2 LOXL2 GNA15 CCR6 MMP12	1.85e-06	200	128	7	1adebb306112bfc4926678de80f70d35dd57a586
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FGD2 RGS1 RGS7 SLC46A3 SULF2 GNA15	5.40e-06	153	128	6	c81a88d3f707487c511020d3960a1c41e706c6a0
ToppCell	droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FGD2 SLC46A3 PTPRO SV2B MMP12 ATP2B2	7.50e-06	162	128	6	8a488ecd25ef41468c3c7766eb936dbc2f7665a9
ToppCell	Severe-Lymphoid-NK-CCR7+_T\|Severe / Condition, Lineage, Cell class and cell subclass	NPTX1 RBL2 PEX1 URGCP SYNE2 PRKCQ	7.76e-06	163	128	6	8f0d8c124f1569a5a6bc1db7581989f24d63cca3
ToppCell	droplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FGD2 SLC46A3 SV2B GNA15 MMP12 ATP2B2	8.04e-06	164	128	6	a67dd181eba275c191f4d0cab13df30eaa3ad913
ToppCell	LPS-antiTNF-Myeloid-Dendritic_cells-mDC\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FGD2 RGS1 LRP8 SULF2 PTPRO GNA15	9.23e-06	168	128	6	2dca1c4a33b6da9357fa3b2a523af19baab1c21c
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	NEB FAM120A GNPDA2 CMTM5 DSEL DNAH11	9.54e-06	169	128	6	29db25e7c5f31d98a08a35d7ec5ade203242bc50
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	NEB FAM120A GNPDA2 CMTM5 DSEL DNAH11	9.54e-06	169	128	6	b1611e61f635f8f9b87250e026ad30999cbee041
ToppCell	metastatic_Lymph_Node-T/NK_cells-Exhausted_Tfh\|metastatic_Lymph_Node / Location, Cell class and cell subclass	C6orf163 CHN1 RGS1 SCUBE1 SRGAP3 GNA15	9.54e-06	169	128	6	ad9054ee09033b648a76baf1b2ec4a6ab1394bde
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FGD2 SLC46A3 PTPRO SV2B MMP12 ATP2B2	9.87e-06	170	128	6	138235227fc4c3d660c3a06e8e5167bf64f076b3
ToppCell	facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FGD2 RGS1 SLC46A3 SULF2 PTPRO MMP12	9.87e-06	170	128	6	6686d1797988216c0d9417f21a2537369abce410
ToppCell	Immune-dendritic_cell\|World / Lineage, Cell type, age group and donor	FGD2 RGS1 RGS7 SULF2 LOXL2 CCR6	1.02e-05	171	128	6	6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FGD2 RGS1 SLC46A3 SULF2 PTPRO MMP12	1.02e-05	171	128	6	7c4362eeacbe52d7f4fdf93c841d7b59526328c1
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RELN DPP10 NEB RGS7 PRKCQ ATP2B2	1.02e-05	171	128	6	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FGD2 SLC46A3 PTPRO SV2B GNA15 MMP12	1.09e-05	173	128	6	f66aebceb3eb389bc5ff6c0b398d6f4e9959a14f
ToppCell	P28-Endothelial-lymphatic_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN MROH2A CP SULF2 HOXD8 PRKCQ	1.24e-05	177	128	6	6e330aa3c87fd640526b746a9deb3b2250d2518c
ToppCell	P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN MROH2A CP SULF2 HOXD8 PRKCQ	1.24e-05	177	128	6	e96a7e4544710aaab8bd2800ecff9667880a8bf4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPTX1 DPP10 SULF2 SV2B DNAH6 ANO3	1.24e-05	177	128	6	7e799333307448c6a94d1f33dbc59c543336f45e
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CCDC18 NOL10 NEB MELK RGS14 DDX39A	1.32e-05	179	128	6	af03705a783e77f75c44fdfa793cfdccbf9dd91c
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAP2 PECAM1 CP PTGS2 SULF2 MPPED2	1.32e-05	179	128	6	1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PECAM1 ABCG1 SCUBE1 SULF2 SYNE2 PXN	1.37e-05	180	128	6	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPTX1 FGD2 MAP2 RGS7 ABCG1 DNAH9	1.45e-05	182	128	6	398ce074a04f6482470b488f1affae4af7d2ec58
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN MROH2A NEB DNAH9 ANO3 DNAH11	1.55e-05	184	128	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN MROH2A NEB DNAH9 ANO3 DNAH11	1.55e-05	184	128	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN MROH2A NEB DNAH9 ANO3 DNAH11	1.55e-05	184	128	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RELN PECAM1 ABCG1 SULF2 HOXD8 MICAL2	1.59e-05	185	128	6	3be9e05b929ac4d956b1d53284072f668a6c1959
ToppCell	facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN ACACB PECAM1 CP HOXD8 PRKCQ	1.59e-05	185	128	6	59acaf025353405948dc34ccccf37ec5c08ea903
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RELN PECAM1 ABCG1 SULF2 HOXD8 MICAL2	1.59e-05	185	128	6	c3dd64a726cb8a1fe048683c266b7532a714a52e
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NPTX1 CHN1 RGS14 SCUBE1 SV2B ANO3	1.64e-05	186	128	6	56c139e679d640ea901ead657a8e8887e0fca098
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPTX1 CHN1 SV2B MICAL2 MPPED2 ANO3	1.69e-05	187	128	6	f18628ffc7ff7c762b8339ba8822cf0c3157f469
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FGD2 CHST11 RGS1 GNA15 MMP12 DNAH9	1.75e-05	188	128	6	239bec13476dd43bebc2c6eba8d1fe35f2744673
ToppCell	Control-Myeloid-Macrophage_Alveolar\|Control / Disease state, Lineage and Cell class	GPD1 ACACB PECAM1 ABCG1 SVIL SPOCD1	1.80e-05	189	128	6	937e876122bc4b94372a4104e9c1a9068c232018
ToppCell	Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	GPD1 PECAM1 SELENON ABCG1 PTPRO SPOCD1	1.80e-05	189	128	6	c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 CP ACTN4 SULF2 SVIL SYNE2	1.80e-05	189	128	6	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 CP ACTN4 SULF2 SVIL SYNE2	1.80e-05	189	128	6	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ACACB ENPP3 IYD SYNE2 PXN KDM4B	1.80e-05	189	128	6	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	Hippocampus-Neuronal-Excitatory\|Hippocampus / BrainAtlas - Mouse McCarroll V32	NPTX1 CHN1 RGS14 SV2B MICAL2 ANO3	1.80e-05	189	128	6	4b90d181eb0a42814eeb23bc82e52fd3a12392a7
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPTX1 CHN1 SV2B MICAL2 MPPED2 ANO3	1.80e-05	189	128	6	c3df0e3c50af8f1cfb4d790e668bd7f42b276992
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPTX1 CHN1 SV2B MICAL2 ANO3 SEC14L5	1.85e-05	190	128	6	d594da827e3c16644952b9589cc12b947ce36279
ToppCell	IPF-Myeloid-Macrophage_Alveolar\|Myeloid / Disease state, Lineage and Cell class	GPD1 ACACB PECAM1 ABCG1 SVIL SPOCD1	1.85e-05	190	128	6	2592765016f291565697265800a232b2edef3792
ToppCell	Control-Myeloid-Macrophage_Alveolar\|Myeloid / Disease state, Lineage and Cell class	GPD1 ACACB PECAM1 ABCG1 SVIL SPOCD1	1.91e-05	191	128	6	a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 ATP8B1 SELENON PTGS2 SULF2 LOXL2	1.97e-05	192	128	6	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	normal_Lung\|World / Location, Cell class and cell subclass	GPD1 ANXA2 PECAM1 GABARAPL1 SVIL SPOCD1	2.09e-05	194	128	6	affae83d7f982d18117f5b95705f09809f304b0b
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHN1 RGS7 SV2B SRGAP3 MICAL2 ATP2B2	2.15e-05	195	128	6	787e95fb59c40bba784544b662fac37606ae1427
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-CD163+CD14+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	MORC1 RGS1 MICAL2 GNA15 CCR6 DDX39A	2.15e-05	195	128	6	a04ddf1f191fd814e67fb28503096e1a07ccb79a
ToppCell	critical-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	RBL2 ACTN4 GABARAPL1 SRGAP3 SYNE2 ARHGEF3	2.21e-05	196	128	6	c861f017aa9050282aa81c5a445bae399df00e4f
ToppCell	wk_15-18-Endothelial-Lymph_endothelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	RELN ANXA2 PECAM1 SELENON SULF2 HOXD8	2.21e-05	196	128	6	ff627244d7f5fd6a2ec009dae32d3509f0e2d95e
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	STEAP4 CP TRIM24 SYNE2 PRKCQ DSEL	2.27e-05	197	128	6	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-Treg\|ICU-SEP / Disease, condition lineage and cell class	CHN1 MELK RGS1 SYNE2 CCR6 ATIC	2.27e-05	197	128	6	c3ee2d522fbfe67069ddba2d1abfc4f5ca230c26
ToppCell	COVID-19-Myeloid-Migratory_DC\|COVID-19 / Condition, Lineage and Cell class	RGS1 SULF2 LOXL2 TOMM34 CCR6 MPPED2	2.27e-05	197	128	6	b6d6cdae33753c1e38394f1f879e00b87f9c0496
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GPD1 FGD2 PECAM1 ABCG1 PTPRO SPOCD1	2.34e-05	198	128	6	e125eb8aa57c172e5518874da1bd25998292f5e2
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GPD1 FGD2 PECAM1 ABCG1 PTPRO SPOCD1	2.34e-05	198	128	6	0baeb8e2c199ff10bb5c829c523546af3c9227c1
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-mDC\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NPTX1 FGD2 RGS1 SULF2 GNA15 MMP12	2.34e-05	198	128	6	e8002972410e4803d85263ba2642e6855cef83e9
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	GPD1 FGD2 ABCG1 PTPRO GNA15 SPOCD1	2.47e-05	200	128	6	6e50272d172b491200d9a255ed08e6d6998cfe02
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	GPD1 FGD2 ABCG1 PTPRO GNA15 SPOCD1	2.47e-05	200	128	6	840be665639a53ba9bafc19f7a81ca1e0436e329
ToppCell	Sepsis-Int-URO-Lymphocyte-T/NK-Treg\|Int-URO / Disease, condition lineage and cell class	RGS1 ABCG1 SRGAP3 LOXL2 SYNE2 CCR6	2.47e-05	200	128	6	47f265336bc3b8052c0cac730ac9afd41cd8fc43
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-mDC\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FGD2 RGS1 RGS7 SULF2 PTPRO GNA15	2.47e-05	200	128	6	f78968d4b4d907094b2c44dcf5ac557ae94e4484
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-mDC\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FGD2 RGS1 SULF2 GNA15 ACCSL	3.99e-05	132	128	5	f8e2ba53063007d7507f1837ad669b0e4333cd23
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MORC1 GPD1 RELN SVIL PRKCQ	5.11e-05	139	128	5	9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b
ToppCell	Control-Hematopoietic_Mast-Mast_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ENPP3 RGS1 SCUBE1 GNA15 CCR6	5.65e-05	142	128	5	a81f7ea4516a869c7c9b9a3f4ef74844ff9fffcd
ToppCell	Control-Hematopoietic_Mast-Mast_cells-T-cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ENPP3 RGS1 SCUBE1 GNA15 CCR6	5.65e-05	142	128	5	70f8c1be134835e0d21e6d426b7122f0f5d3d3e5
ToppCell	Control-Hematopoietic_Mast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ENPP3 RGS1 SCUBE1 GNA15 CCR6	5.65e-05	142	128	5	db9b7acbab730ae391a362f1ca8177507e52250d
ToppCell	Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Klk6_(Klk6)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GJB4 ENPP3 SLC4A5 SEC14L5	6.16e-05	74	128	4	a53f2e1f1044f3745a1eff5ba6275c8f1fbf3ae0
ToppCell	Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Klk6_(Klk6)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GJB4 ENPP3 SLC4A5 SEC14L5	6.16e-05	74	128	4	ae547cb8bbd780b19d9c6b555c27dad932dcc753
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GPD1 MROH2A CP RGS8 SVIL	6.24e-05	145	128	5	590ba937c741ae67460f303eca88b1cd3ac87f64
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFAP300 SPOCD1 DNAH6 DNAH9 DNAH11	6.88e-05	148	128	5	d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFAP300 SPOCD1 DNAH6 DNAH9 DNAH11	6.88e-05	148	128	5	c8e93b87212f55774223caa385859c566fa1981f
ToppCell	facs-Spleen-nan-24m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPTX1 ANXA2 CHST11 RGS1 SULF2	8.30e-05	154	128	5	bd283c2367afb99294e7576a0c0167eb7c69ad6b
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ANXA2 HOXC8 PRKCQ TAS2R60	9.21e-05	82	128	4	5d2fb64c01739258d5ab17d533ef41e2323605f2
ToppCell	356C-Fibroblasts-Fibroblast-D-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FGD2 PECAM1 LRP8 ABCG1 PTPRO	9.65e-05	159	128	5	299e2162a82e31196d7f3a110c2db622349edfff
ToppCell	356C-Fibroblasts-Fibroblast-D\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FGD2 PECAM1 LRP8 ABCG1 PTPRO	9.65e-05	159	128	5	0a3a363b30a8c741e1a3e2525725108d03c21776
ToppCell	LPS-IL1RA-Myeloid-Dendritic_cells-pDC\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FGD2 RGS1 RGS7 SULF2 GNA15	9.94e-05	160	128	5	dee756a2dc9725520d439e7273c489c2284015d8
ToppCell	PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IYD CP MICAL2 ATP2B2 SLC4A5	1.02e-04	161	128	5	c4970501c038ed36de447da70eabff020ad78713
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|367C / Donor, Lineage, Cell class and subclass (all cells)	IPO8 URGCP SLC46A3 SYNE2 PRKCQ	1.02e-04	161	128	5	f470b662566131dfe69a2fd01186ac8491196396
ToppCell	PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IYD CP MICAL2 ATP2B2 SLC4A5	1.02e-04	161	128	5	41a89a3d99a9bd6039a3d881d1d9dcd18bc07f25
ToppCell	Children_(3_yrs)-Immune-dendritic_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RGS1 LRP8 SULF2 LOXL2 CCR6	1.02e-04	161	128	5	cd41abb7ae659d3d314281783a0aaad562b26037
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PEX1 CP SYNE2 PXN PRKCQ	1.02e-04	161	128	5	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NOL10 NEB RGS1 GNA15 CCR6	1.05e-04	162	128	5	adf545cf9357556e2ce7affed01c2f6a24b0581d
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN MROH2A PECAM1 HOXD8 PRKCQ	1.08e-04	163	128	5	c21114826bee1b05b411984326fef6b6e0d05316
ToppCell	P07-Endothelial-lymphatic_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN MROH2A SULF2 HOXD8 PRKCQ	1.08e-04	163	128	5	5cbab3d03bb1af9391ecad635d6eea1dd42c1337
ToppCell	P07-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN MROH2A SULF2 HOXD8 PRKCQ	1.08e-04	163	128	5	322ba94c3ec1e1859c2e2195ecb3f7dab8d190f6
ToppCell	356C-Lymphocytic-ILC-ILC-3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CFAP300 RGS1 SRGAP3 LOXL2 CSTF3	1.08e-04	163	128	5	2dbdcbc4c187aad3db837d191cc78662a75dd0b5
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN MROH2A PECAM1 HOXD8 PRKCQ	1.08e-04	163	128	5	5d49414432db259a19df50d7944581d00b69f537
ToppCell	facs-Spleen-nan-3m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANXA2 SELENON RGS1 SULF2 MICAL2	1.12e-04	164	128	5	a187bd5beca017ef657ef07c006e7f94ea3b911b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RELN HIGD1C ABCG1 SULF2 SV2B	1.12e-04	164	128	5	a784f47f67a5eda84d58ad7d9400e3978edbb487
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RELN HIGD1C ABCG1 SULF2 SV2B	1.12e-04	164	128	5	1a1795969673232191425dde84ab24ee6a98143f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RELN HIGD1C ABCG1 SULF2 SV2B	1.12e-04	164	128	5	8f074940afdbda88a4b697a7ddc687e09a4b818b
Drug	Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A	MORC1 GPD1 ACACB STEAP4 RGS14 PXN PRKCQ DNAH9 ATP2B2	1.60e-06	196	127	9	2270_UP
Disease	Rheumatoid Arthritis	CP PTGS2 TMPO CCR6 PRKCQ ATIC MMP12	1.03e-05	174	126	7	C0003873
Disease	renal cell carcinoma (biomarker_via_orthology)	ANXA2 ANXA2P2 PTGS2	2.67e-05	14	126	3	DOID:4450 (biomarker_via_orthology)
Disease	galectin-4 measurement	ACTN4 ARHGEF3	1.08e-04	4	126	2	EFO_0020398
Disease	low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram	RELN CHST11 SULF2	1.44e-04	24	126	3	EFO_0004611, EFO_0006329, EFO_0007871
Disease	medulloblastoma (is_marker_for)	KDM4C KDM4B	1.79e-04	5	126	2	DOID:0050902 (is_marker_for)
Disease	14-3-3 protein beta/alpha measurement	TOMM34 ARHGEF3	1.79e-04	5	126	2	EFO_0021957
Disease	hyperthyroidism (biomarker_via_orthology)	ANXA2 ANXA2P2 CP	2.30e-04	28	126	3	DOID:7998 (biomarker_via_orthology)
Disease	stem Cell Growth Factor beta measurement	OMA1 KDM4C CHST11 PNLIPRP3	3.05e-04	75	126	4	EFO_0008292
Disease	fatty liver disease (implicated_via_orthology)	ACACB PTGS2 HADHB	3.13e-04	31	126	3	DOID:9452 (implicated_via_orthology)
Disease	Melanoma, Cloudman S91	KDM4C PXN	3.75e-04	7	126	2	C0009075
Disease	Melanoma, B16	KDM4C PXN	3.75e-04	7	126	2	C0004565
Disease	Melanoma, Experimental	KDM4C PXN	3.75e-04	7	126	2	C0025205
Disease	Melanoma, Harding-Passey	KDM4C PXN	3.75e-04	7	126	2	C0018598
Disease	memory performance	OMA1 KDM4C CHST11 NEB RGS7 SCUBE1 SYNE2 DSEL	3.85e-04	409	126	8	EFO_0004874
Disease	mean platelet volume	GNPDA1 COL6A6 NELFCD PECAM1 ACTN4 BCLAF3 SVIL SYNE2 HADHB ARHGEF3 TAF11 DDX39B SEC14L5	4.33e-04	1020	126	13	EFO_0004584
Disease	glycylvaline measurement	PRKCQ DNAH11	4.98e-04	8	126	2	EFO_0021129
Disease	melanoma	KDM4C CP PTGS2 PTPRO TAS2R60 KDM4B	7.05e-04	248	126	6	C0025202
Disease	virologic response measurement, response to abacavir	IYD MANEA SPOCD1	7.73e-04	42	126	3	EFO_0006905, EFO_0006906
Disease	alopecia areata (is_marker_for)	KDM4C KDM4B	7.96e-04	10	126	2	DOID:986 (is_marker_for)
Disease	Weight Gain	ANXA2 ABCG1 MMP12 DNAH11	9.75e-04	102	126	4	C0043094
Disease	Primary Ciliary Dyskinesia	CFAP300 DNAH9 DNAH11	1.07e-03	47	126	3	C4551720
Disease	Congenital myopathy (disorder)	NEB SELENON	1.16e-03	12	126	2	C0270960
Disease	autistic disorder (is_marker_for)	RELN PECAM1	1.16e-03	12	126	2	DOID:12849 (is_marker_for)
Disease	IGF-1 measurement	ACACB BAZ1B C6orf163 ACTN4 CHST11 FAM120A SYNE2 KDM4B	1.21e-03	488	126	8	EFO_0004627
Disease	response to fenofibrate	KDM4C ENPP3 SCUBE1	1.29e-03	50	126	3	GO_1901557
Disease	adipic acid mesurement	DPP10 KDM4C	1.37e-03	13	126	2	EFO_0010455
Disease	pneumonia, COVID-19	OMA1 MAP2 MELK ANO3	1.43e-03	113	126	4	EFO_0003106, MONDO_0100096
Disease	systemic scleroderma (is_marker_for)	PECAM1 PTGS2 CCR6	1.52e-03	53	126	3	DOID:418 (is_marker_for)
Disease	colonic neoplasm, overall survival	DPP10 RGS1	1.59e-03	14	126	2	EFO_0000638, EFO_0004288
Disease	Acute Cerebrovascular Accidents	PTGS2 RGS7 MMP12	1.61e-03	54	126	3	C0751956
Disease	Liver Cirrhosis, Experimental	GNPDA1 RBL2 ANXA2 IYD STEAP4 TRIM24 PTGS2 ABCG1 PTPRO LOXL2	1.83e-03	774	126	10	C0023893
Disease	DNA methylation	GNPDA1 DPP10 PTGS2 SVIL MMP12 DNAH6 ATP2B2 ANO3 DNAH11	2.06e-03	656	126	9	GO_0006306
Disease	response to acetylsalicylate	OMA1 SCAP	2.09e-03	16	126	2	GO_1903492
Disease	Cerebrovascular accident	PTGS2 RGS7 MMP12	2.39e-03	62	126	3	C0038454
Disease	cortical thickness	OMA1 RELN ACTN4 PPP4R3A LRP8 ABCG1 SCUBE1 SULF2 SRGAP3 UBTF MPPED2 KDM4B	2.95e-03	1113	126	12	EFO_0004840
Disease	bipolar disorder (is_marker_for)	RELN PTGS2	2.95e-03	19	126	2	DOID:3312 (is_marker_for)
Disease	emphysema pattern measurement	SVIL MMP12	2.95e-03	19	126	2	EFO_0005850
Disease	severe acute respiratory syndrome, COVID-19	OMA1 RELN NOL10 SCUBE1 SRGAP3 PXN ARHGEF3	3.15e-03	447	126	7	EFO_0000694, MONDO_0100096
Disease	Arthrogryposis	VPS33B DYNC1H1	3.60e-03	21	126	2	C0003886
Disease	Major Depressive Disorder	MORC1 RELN MAP2 PTGS2 LRP8	3.96e-03	243	126	5	C1269683

Protein segments in the cluster

Peptide	Gene	Start	Entry
YSPDSLMKYLEFAKR	ACCSL	336	Q4AC99
FKKVLYEMGPEYSSN	GPT2	316	Q8TD30
RQTMSKKYPFILEVY	CEBPZOS	41	A8MTT3
MVAKDYPFYLTVKRA	ARHGEF3	1	Q9NR81
KAYYLAKTMADVPFQ	ABCG1	496	P45844
AFQISKEYERFSKYM	DDX39B	126	Q13838
KEYERFSKYMPNVKV	DDX39B	131	Q13838
FQISKEYERFSKYMP	DDX39A	126	O00148
EYERFSKYMPSVKVS	DDX39A	131	O00148
SKFSDFLLDPYKYMT	BAZ1B	286	Q9UIG0
RPDEKAIMTYVSSFY	ACTN4	251	O43707
FAFYKKARSMTDVYL	CCR6	71	P51684
AVGMYSKEKEYVPFQ	DNAH11	1676	Q96DT5
QKVFDRYKSYSPYDM	ANXA2	226	P07355
RMAFQKYINYTFPKL	C6orf163	286	Q5TEZ5
QKVFDRYKSYSPYDM	ANXA2P2	226	A6NMY6
YKPKAYLRDFMYVSQ	HADHB	331	P55084
PDSFKSREYYITMVK	DPP10	311	Q8N608
MPEEKLYKVYTFNSV	ATP2B2	591	Q01814
AIKTYKYNAFTFIPM	ATP8B1	96	O43520
MFEKYYAKLEPRDQR	CCDC113	46	Q9H0I3
ETLRPQFEAKYYKME	ANO3	511	Q9BYT9
FYEFRSYYLKPSKMN	NIPSNAP3A	36	Q9UFN0
KVIYTLMEKDSYPRF	RGS1	176	Q08116
MFPTYKYVDINTFRL	MMP12	236	P39900
KDEFYNRYIMKSFLF	PPP4R3A	566	Q6IN85
EYCRIMYDIFPFKKL	INTS13	61	Q9NVM9
VYTPKSAVKNEEYFM	MELK	426	Q14680
IYKYSPFKTEAELMQ	MORC1	171	Q86VD1
DKFQLTFPLRTNYMY	NPTX1	226	Q15818
MLSPREKIFYYFSNS	RBL2	1066	Q08999
YIYDFPEMFRQALFK	ACACB	1716	O00763
AKMYYSAVDPTKDIF	CP	536	P00450
FMADLVKQDYYRFPS	MPPED2	126	Q15777
FKIDMPHRFKVYNYK	PRKCQ	226	Q04759
YFIDVLMKKFEYSPS	PNLIPRP3	146	Q17RR3
GKKTYFIVMQSVFYP	PIP5KL1	196	Q5T9C9
MPFAEDKTYKYICRN	MAVS	1	Q7Z434
YIMEPSIFNTLKRYF	NELFCD	56	Q8IXH7
MSSYFVNPLYSKYKA	HOXD8	1	P13378
LSFKYVKTFNMDEYV	GNPDA1	61	P46926
SMYKDYIRPRFFSES	HIGD1C	81	A8MV81
FPGERTYNTKVYKMF	LOXL2	236	Q9Y4K0
FYREKEGKPFYQMTS	PECAM1	536	P16284
PSYKEKMAQAYDFAL	CSTF3	116	Q12996
YTNVYRMFSKEPQKS	GLYATL1	71	Q969I3
TMEEFKDFNKYVAYI	KDM4B	21	O94953
PSMEEFREFNKYLAY	KDM4C	21	Q9H3R0
YQSFNEYRKRFMLKP	PTGS2	446	P35354
EYRKRFMLKPYESFE	PTGS2	451	P35354
RMEESFSSKYVPKYV	TMPO	381	P42167
FKRAIGYYSATSKPM	FAM120A	321	Q9NZB2
PYKVTTFEKRYAAAM	GNA15	121	P30679
KVKLMVNPFAYEEYR	NOL10	411	Q9BSC4
FYRYKTKTGNALPMF	MANEA	251	Q5SRI9
FYGTMIFTYLKPRKS	OR8H3	251	Q8N146
MYFSDFSKPRFVYLE	RELN	1171	P78509
GVFRKYVVEMFYFNP	PTPRO	556	Q16827
DFYEKMYTLSTQKFI	KICS2	141	Q96MD2
KAYCRKDYFDMFAPK	PXN	461	P49023
SYRKDDFVMAFFKDP	CFAP300	56	Q9BRQ4
RLFFPVIYDVKYLMK	CNOT7	186	Q9UIV1
YDKNFRFYMTTKMPN	DNAH6	3161	Q9C0G6
FRKCIEKPYMNYTTQ	BCLAF3	611	A2AJT9
MKFQYKEDHPFEYRK	GABARAPL1	1	Q9H0R8
MSFESYLSYDQPRKK	ELOA	431	Q14241
RELFGFKSYLSKYQM	CCDC18	406	Q5T9S5
NKMEYMTDYFPRINF	ENPP3	381	O14638
MKFQYKEVHPFEYRK	GABARAPL3	1	Q9BY60
YISRPTEKKVFTYFM	GJB4	176	Q9NTQ9
VDKFPLFMAVYKVCY	GPD1	316	P21695
LSFKYVKTFNMDEYV	GNPDA2	61	Q8TDQ7
MSSYFVNPLFSKYKA	HOXC8	1	P31273
PFLKMYSEYVKNFER	FGD2	191	Q7Z6J4
AMKLSPYYKVFEEDA	DYNC1H1	1506	Q14204
NLFFPSIYDVKYLMK	CNOT8	186	Q9UFF9
SSYFPAFKAMYRDVV	DNAH9	286	Q9NYC9
TYDAYPKFIESAKIM	CHN1	356	P15882
YFKYTAQESKEMFPR	SCUBE1	956	Q8IWY4
NYFKYTAQESREMFP	SCUBE2	966	Q9NQ36
VYKYPFELVMAAYEK	SEC14L5	11	O43304
FAYIYFSTRKIDMVK	SCAP	296	Q12770
DIDFKYIPYKFMNRY	DSEL	606	Q8IZU8
ILPDESKFNMYRLYF	PEX1	1116	O43933
AMEKYSPKFEIYSEN	COL6A6	1246	A6NMZ7
YRKIYSAYMDKASDP	LRP8	471	Q14114
VMYLSKFYELFRGTP	MICAL2	611	O94851
YPEKEMVKRSQEFYE	IYD	81	Q6PHW0
APMKYSKYRFSTAVV	KBTBD12	476	Q3ZCT8
YIRMKFDIFEDYASP	IPO8	376	O15397
EFALKVFPMYRYFVT	MROH2A	251	A6NES4
MQFYARAKLFYQEVP	NTMT2	66	Q5VVY1
VIKSYAKFSATPRYM	PSMC2	416	P35998
RSYCEKFYLFPLKMI	TAS2R60	186	P59551
IYKLMKSDSYPRFIR	RGS7	426	P49802
KDSYPRFLRSKMYLD	RGS8	156	P57771
FPDMIRYFQDEEYKS	SV2B	411	Q7L1I2
ETFAKFYRSVDYNMP	SVIL	1306	O95425
TMYNFRYPTTEELKT	SYNE2	4486	Q8WXH0
YEMYRRSAFPKAAIK	TAF11	121	Q15544
MFPQLDDEATRKAYY	GNL3L	111	Q9NVN8
EGFKNLFYRTYMLFK	SLC46A3	236	Q7Z3Q1
SKLQEYMFNRPYSRK	OMA1	376	Q96E52
YMFNRPYSRKLEAEA	OMA1	381	Q96E52
LDFLMFNYSVPSYLK	CHST11	336	Q9NPF2
FAYDAFKIYRTEMAP	CMTM5	201	Q96DZ9
KYAGFMVPYFLRKFF	TAS2R1	146	Q9NYW7
MKESTTKYYFILSPY	URGCP	376	Q8TCY9
EALEKYPMAYVDYKT	TOMM34	96	Q15785
IFRTYPAVKMKYAEN	GTF2H1	196	P32780
YSMYSKPEDFVADFR	TRIM24	956	O15164
YKYFKDYRQMIIEPT	TIMM50	116	Q3ZCQ8
EMFYFTKFKEYVNGS	SRGAP3	436	O43295
MVSFNSKVEKRYYQP	SPOCD1	1036	Q6ZMY3
RRLEVAMYPFKKVSY	SELENON	416	Q9NZV5
AMYPFKKVSYLPFTE	SELENON	421	Q9NZV5
LKKPFAQEEDSAMYY	TRAV16	91	A0A0A6YYK6
YDDAMQFSKKRRYLP	ZNF281	531	Q9Y2X9
LPEYKRFFVMGITSY	TMPRSS12	276	Q86WS5
KYYPINMDFKPNFIT	SLC4A5	661	Q9BY07
PYVYEKKDNTFRMAI	STEAP4	226	Q687X5
MKFDSYARFVKSPLY	RGS14	166	O43566
DYFRKQYSKGVSQMP	ATIC	191	P31939
EFAYMKALYERKFPV	RIOK2	161	Q9BVS4
PFYEDKSGMSKYFET	MAP2	561	P11137
KFMKNRDVYSSDYFS	USP24	2126	Q9UPU5
KNGLVYMKYDTPFIF	TGM1	481	P22735
LTPYFRFFMEKRAKY	UBTF	116	P17480
DPRVKYLCYTMKVFT	TUT7	1141	Q5VYS8
KSMPYEFDIRVPFYV	SULF2	331	Q8IWU5
YKVIFSPQKFYACEM	VPS33B	111	Q9H267
VKKRYDFMVFAYREP	ZPBP2	126	Q6X784
SKLSDMPLKSFYRYV	UGGT1	1026	Q9NYU2
DFEKYKTRYSSPVDM	NEB	3321	P20929